Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02BE01	ADOL	G	Paracetamol - 500mg	500mg	Caplet	81,974 L.L
N02BE01	ADOL	G	Paracetamol - 250mg	250mg	Suppository	124,977 L.L
N02BE01	ALGIVIC	G	Paracetamol - 250mg	250mg	Suppository	215,015 L.L
N02BE01	ADOL	G	Paracetamol - 500mg	500mg	Suppository	131,697 L.L
N02BE01	ALGIVIC	G	Paracetamol - 500mg	500mg	Suppository	147,183 L.L
N02BE01	ADOL	G	Paracetamol - 125mg	125mg	Suppository	107,507 L.L
N02BE01	ALGIVIC INFANT	G	Paracetamol - 125mg	125mg	Suppository	199,657 L.L
N02BE01	ADOL	G	Paracetamol - 250mg/5ml	250mg/5ml	Suspension, alcohol free	192,169 L.L
N02BE51	ADOL EXTRA	G	Paracetamol - 500mg, Caffeine - 65mg		Caplet	122,290 L.L
N02BE51	ALGIN ADULTS	G	Paracetamol - 400mg, Caffeine - 50mg		Suppository	195,817 L.L
N02BE51	A.B.C.-COLD	G	Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg		Tablet, film coated	534,977 L.L
N02BG06	ACUPAN	B	Nefopam HCl - 20mg	20mg	Injectable solution	365,525 L.L
N02CC05	ALMOVITAE	G	Almotriptan - 12.5mg	12.5mg	Tablet, film coated	1,148,985 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	35,423,371 L.L
N02CX01	APIZINE	G	Pizotifen - 0.25mg/5ml	0.25mg/5ml	Syrup	505,541 L.L
N03AF01	APO-CARBAMAZEPINE	G	Carbamazepine - 200mg	200mg	Tablet	727,019 L.L
N03AX12	APO-GABAPENTIN	G	Gabapentin - 300mg	300mg	Capsule	2,527,768 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 5mg	5mg	Tablet, orally disintegrating	1,463,444 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 10mg	10mg	Tablet, orally disintegrating	2,422,948 L.L
N05AX12	ABIPREX 10	G	Aripiprazole - 10mg	10mg	Tablet	1,075,074 L.L
N05AX12	ATYPRAL	G	Aripiprazole - 10mg	10mg	Tablet	712,237 L.L
N05AX12	ABIPREX 15	G	Aripiprazole - 15mg	15mg	Tablet	1,075,074 L.L
N05AX12	ATYPRAL	G	Aripiprazole - 15mg	15mg	Tablet	712,237 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
N05BA08	ANXYL	G	Bromazepam - 3mg	3mg	Tablet, scored	167,660 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.5mg	0.5mg	Tablet, scored	169,324 L.L
N05BA12	ALPROX	G	Alprazolam - 0.5mg	0.5mg	Tablet	383,955 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.25mg	0.25mg	Tablet, scored	115,570 L.L
N05BA12	ALPROX	G	Alprazolam - 1mg	1mg	Tablet	895,895 L.L
N06AB05	APO-PAROXETINE	G	Paroxetine (HCl) - 20mg	20mg	Tablet	983,693 L.L

...